bioAffinity Technologies, Inc.

NasdaqCM:BIAF Stock Report

Market Cap: US$5.5m

bioAffinity Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIAF?
Owner TypeNumber of SharesOwnership Percentage
Institutions127,9662.85%
Individual Insiders227,9835.08%
Hedge Funds242,7575.4%
General Public3,893,19886.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 764.7%.

Top Shareholders

Top 25 shareholders own 13.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.4%
Sabby Management, LLC
242,757US$298.6k0%2.7%
1.34%
Richard Crumly
60,251US$74.1k0%no data
1.31%
Michael Bigger
58,682US$72.2k1,530%no data
1.31%
District 2 Capital LP
58,682US$72.2k1,520%1.07%
0.81%
Steven Girgenti
36,295US$44.6k-0.01%no data
0.65%
L1 Capital Pty. Limited
29,213US$35.9k0%no data
0.5%
Gary Rubin
22,307US$27.4k0%no data
0.48%
Roby Joyce
21,656US$26.6k-0.01%no data
0.37%
Scientech Research LLC
16,583US$20.4k0%0.01%
0.23%
The Vanguard Group, Inc.
10,429US$12.8k670%no data
0.15%
Maria Zannes
6,674US$8.2k-28.6%no data
0.11%
Robert Anderson
4,798US$5.9k-12.2%no data
0.093%
Geode Capital Management, LLC
4,181US$5.1k0%no data
0.087%
Peter Knight
3,914US$4.8k-0.03%no data
0.08%
James Edwards
3,604US$4.4k-9.99%no data
0.074%
Stuart Diamond
3,303US$4.1k0%no data
0.056%
Tower Research Capital Europe Limited
2,499US$3.1k2,300%no data
0.041%
Timothy Zannes
1,825US$2.2k0%no data
0.041%
Jamie Platt
1,824US$2.2k-0.05%no data
0.04%
Sheaff Brock Investment Advisors, LLC
1,791US$2.2k0%no data
0.04%
Allworth Financial, L.P.
1,791US$2.2k0%no data
0.037%
Bank of America Corporation
1,684US$2.1k28,000%no data
0.031%
Xavier Reveles
1,398US$1.7k0%no data
0.019%
Roberto Rios
833US$1.0k2,880%no data
0.019%
IFP Advisors, LLC
833US$1.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 19:02
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

bioAffinity Technologies, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anthony VendettiMaxim Group